Approach to the management of recently diagnosed inflammatory bowel disease patients: a user's guide for adult and pediatric gastroenterologists

M Agrawal, EA Spencer, JF Colombel, RC Ungaro - Gastroenterology, 2021 - Elsevier
Inflammatory bowel diseases (IBDs), including Crohn's disease and ulcerative colitis, are
chronic, progressive, immune-mediated diseases of adults and children that have no cure …

Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases

AB Kunnumakkara, D Bordoloi… - British journal of …, 2017 - Wiley Online Library
Curcumin, a yellow pigment in the Indian spice Turmeric (Curcuma longa), which is
chemically known as diferuloylmethane, was first isolated exactly two centuries ago in 1815 …

Management of paediatric ulcerative colitis, part 1: ambulatory care—an evidence-based guideline from European Crohn's and Colitis Organization and European …

D Turner, FM Ruemmele… - Journal of pediatric …, 2018 - journals.lww.com
Background: The contemporary management of ambulatory ulcerative colitis (UC) continues
to be challenging with∼ 20% of children needing a colectomy within childhood years. We …

[HTML][HTML] Evidence-based nonpharmacologic strategies for comprehensive pain care: the consortium pain task force white paper

H Tick, A Nielsen, KR Pelletier, R Bonakdar… - Explore, 2018 - Elsevier
Medical pain management is in crisis; from the pervasiveness of pain to inadequate pain
treatment, from the escalation of prescription opioids to an epidemic in addiction, diversion …

Stress and the brain-gut axis in functional and chronic-inflammatory gastrointestinal diseases: A transdisciplinary challenge

A Labanski, J Langhorst, H Engler… - …, 2020 - Elsevier
The broad role of stress in the brain-gut axis is widely acknowledged, with implications for
multiple prevalent health conditions that are characterized by chronic gastrointestinal …

[HTML][HTML] Antioxidant therapy for treatment of inflammatory bowel disease: does it work?

FA Moura, KQ de Andrade, JCF Dos Santos… - Redox biology, 2015 - Elsevier
Oxidative stress (OS) is considered as one of the etiologic factors involved in several signals
and symptoms of inflammatory bowel diseases (IBD) that include diarrhea, toxic megacolon …

Revisiting inflammatory bowel disease: pathology, treatments, challenges and emerging therapeutics including drug leads from natural products

K Yeshi, R Ruscher, L Hunter, NL Daly… - Journal of clinical …, 2020 - mdpi.com
Inflammatory bowel disease (IBD) is a chronic and life-long disease characterized by
gastrointestinal tract inflammation. It is caused by the interplay of the host's genetic …

Probiotics, prebiotics and synbiotics in inflammatory bowel diseases

K Akutko, A Stawarski - Journal of Clinical Medicine, 2021 - mdpi.com
Inflammatory bowel diseases (IBD), which include Crohn's disease (CD) and ulcerative
colitis (UC), are chronic inflammatory diseases of the digestive tract with periods of …

Benefits and harms of medical cannabis: a scoping review of systematic reviews

M Pratt, A Stevens, M Thuku, C Butler, B Skidmore… - Systematic reviews, 2019 - Springer
Background There has been increased interest in the role of cannabis for treating medical
conditions. The availability of different cannabis-based products can make the side effects of …

Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn “der Deutschen Gesellschaft für Gastroenterologie, Verdauungs-und Stoffwechselkrankheiten …

A Sturm, R Atreya, D Bettenworth… - Zeitschrift für …, 2022 - thieme-connect.com
Im Jahr 2019 wurden etwa 25 500 Patient* innen mit M. Crohn im Krankenhaus stationär
behandelt [1]. Meistens tritt die Erkrankung in der Adoleszenz und im jungen …